The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09).
 
Sun Young Kim
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Roche/Genentech (Inst)
 
Jee Hyun Kim
Honoraria - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche; Roche; Sanofi
Consulting or Advisory Role - Bixink; Daiichi Sankyo/Astra Zeneca; Eisai; Everest Medicine; MSD; Roche; Yuhan
Research Funding - Eisai (Inst); Ono Pharmaceutical (Inst); Roche (Inst)
 
Tae-Yong Kim
No Relationships to Disclose
 
Sook Ryun Park
Stock and Other Ownership Interests - Genome & Company
Consulting or Advisory Role - Genome & Company (Inst)
Research Funding - ImmuneOncia (Inst); Incyte (Inst)
 
Shinkyo Yoon
No Relationships to Disclose
 
Soohyeon Lee
Stock and Other Ownership Interests - Celgene/Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - PharmAbcine
Research Funding - Jeil Pharmaceutical Co
Travel, Accommodations, Expenses - ST Cube
 
Se-Hoon Lee
Honoraria - Amgen; AstraZeneca/MedImmune; Lilly; Merck; Roche
Consulting or Advisory Role - AstraZeneca; BMS/Ono; IMBdx; Janssen; Lilly; Merck; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Lunit; Merck
Travel, Accommodations, Expenses - Novartis
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Sae-Won Han
Honoraria - IMBdx; Ono Pharmaceutical
Consulting or Advisory Role - BeyondBio; Cell Biotech; Ono Pharmaceutical
Research Funding - Arcus Biosciences (Inst); BeyondBio (Inst); GC Pharma (Inst); Genentech (Inst); Hanmi (Inst); IMBdx (Inst); Janssen (Inst); Jeil Pharmaceutical Co (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Mirati Therapeutics (Inst); MSD (Inst); Roche (Inst); Seagen (Inst); Turnstone Bio (Inst)
 
Hongseok Yun
No Relationships to Disclose
 
Sejoon Lee
No Relationships to Disclose
 
Jihun Kim
No Relationships to Disclose
 
Yoon-La Choi
Employment - abion (I)
Stock and Other Ownership Interests - abion (I)
Consulting or Advisory Role - LG Chem
Speakers' Bureau - Takeda; Yuhan
 
Kui Son Choi
No Relationships to Disclose
 
Heejung Chae
No Relationships to Disclose
 
Hyewon Ryu
No Relationships to Disclose
 
Gyeong-Won Lee
No Relationships to Disclose
 
Dae Young Zang
No Relationships to Disclose
 
Joong Ahn
Research Funding - Sanofi